Full-Time
Confirmed live in the last 24 hours
Biotechnology tools for genomic research
$120.5k - $163.1kAnnually
Junior, Mid
Pleasanton, CA, USA
You match the following 10x Genomics's candidate preferences
Employers are more likely to interview you if you match these preferences:
10x Genomics develops products that enhance genomic research, particularly in the life sciences sector. Their main offerings include tools for single-cell analysis, spatial gene expression, and immune profiling, which allow researchers to examine genetic information in great detail. These products help scientists understand complex biological systems and are essential for advancing personalized medicine and research capabilities. The company sells laboratory equipment, consumables like reagents and microfluidic chips, and software solutions for data analysis. Unlike many competitors, 10x Genomics focuses on high-resolution genomic data, catering to academic, clinical, and pharmaceutical researchers. Their goal is to support scientific discovery and the development of new treatments through innovative genomic tools.
Company Size
1,001-5,000
Company Stage
IPO
Total Funding
$214.9M
Headquarters
Pleasanton, California
Founded
2012
Help us improve and share your feedback! Did you find this helpful?
Comprehensive health benefits
Generous time off
Parental leave
PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, at 11:10 a.m. Eastern Time.Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology
FY 2024 revenue of ~$611 million and Q4 2024 revenue of ~$165 million, representing 9% growth sequentiallyPLEASANTON, Calif., Jan. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2024.Preliminary, Unaudited Select Fourth Quarter 2024 Financial ResultsRevenue of approximately $165.0 million for the three months ended December 31, 2024 , representing 9% growth sequentially and a 10% decrease as compared to the corresponding prior year period.for the three months ended , representing 9% growth sequentially and a 10% decrease as compared to the corresponding prior year period. Instruments revenue of approximately $24.4 million , representing 28% growth sequentially and a 37% decrease as compared to the corresponding prior year period. Instruments revenue consists of approximately $10.9 million of Chromium instruments revenue and $13.4 million of Spatial instruments revenue., representing 28% growth sequentially and a 37% decrease as compared to the corresponding prior year period. Instruments revenue consists of approximately of Chromium instruments revenue and of Spatial instruments revenue
Artificial intelligence continues to push the boundaries of science and health exploration. From mapping proteins to neurological networks, these systems continue to make game-changing impacts on the sector. This month, a group of advantageous researchers from the Institute of Psychiatry, Psychology & Neuroscience took AI integration further. They released a study in which AI algorithms were used to predict the metabolic age of patients. Here's what you need to know.Chronological Clock vs Biological ClockTo grasp the importance of this development, it's vital to understand the differences between your chronological and biological age. These two methods of determining the age of your body are used in different ways by healthcare professionals
PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time.Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health
PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ - 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time.